U. Hahn

发表

Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer

A. Schneeweiss, H. Goldschmidt, R. Schlenk, 1999, British Journal of Cancer.

Activating killer‐cell immunoglobulin‐like receptor haplotype influences clinical outcome following HLA‐matched sibling haematopoietic stem cell transplantation

C. Mullighan, J. Szer, S. Heatley, 2018, HLA.

Prevention of catheter-related infections by silver coated central venous catheters in oncological patients.

H. Goldschmidt, B. Jansen, H. Salwender, 1995, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

A Systematic Review of the Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Ganciclovir/Valganciclovir in Allogeneic Haematopoietic Stem Cell Transplant Patients

S. Peake, Morgyn S. Warner, S. Shakib, 2021, Clinical Pharmacokinetics.

Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer.

H. Goldschmidt, M. Wannenmacher, D. Wallwiener, 1997, European journal of cancer.

Autologous Stem Cell Transplantation

L. To, U. Hahn, 1999 .

Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasone

H. Goldschmidt, A. Ho, U. Hegenbart, 2001, Supportive Care in Cancer.

Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation.

N. Schmitz, P. Dreger, A. Zander, 1996, Blood.

Flow cytometric monocyte repartition demonstrates overlap between chronic myelomonocytic leukaemia and myeloid neoplasms with monocytosis.

T. Banović, U. Hahn, D. Ross, 2022, Pathology.

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

L. Campbell, J. Szer, I. Lewis, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early Treatment Intensification with R-ICE Chemotherapy Followed By Autologous Stem Cell Transplantation (ASCT) Using Zevalin-BEAM for Patients with Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL) As Identified By Interim PET/CT Scan Performed after Four

M. Gandhi, I. Lewis, R. Hicks, 2015 .

Maintenance Lenalidomide for Adults Aged 18-65 Years with AML in First Complete Remission after Intensive Chemotherapy: A Phase Ib Dose-Escalation Study of the Australasian Leukemia and Lymphoma Group (ALLG)

I. Lewis, A. Wei, A. Enjeti, 2014 .

Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia

M. Roberts, S. Peake, Morgyn S. Warner, 2017, Antimicrobial Agents and Chemotherapy.

Adequacy of High-Dose Cefepime Regimen in Febrile Neutropenic Patients with Hematological Malignancies

M. Roberts, S. Peake, Morgyn S. Warner, 2015, Antimicrobial Agents and Chemotherapy.

Successful collection and transplantation of peripheral blood stem cells in cancer patients using large‐volume leukaphereses

H. Goldschmidt, R. Haas, U. Hahn, 1996, Journal of clinical apheresis.

Liposomal Amphotericin B (AMBISOME) in Patients with Severe Neutropenia and Antibiotic Resistant Fever

H. Goldschmidt, A. Deboben, R. Haas, 1994 .

Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches

S. Peake, Morgyn S. Warner, S. Shakib, 2022, Transplant infectious disease : an official journal of the Transplantation Society.

Altered Pharmacokinetics of Piperacillin in Febrile Neutropenic Patients with Hematological Malignancy

M. Roberts, S. Peake, Morgyn S. Warner, 2014, Antimicrobial Agents and Chemotherapy.

Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients

J. Gécz, L. To, H. Scott, 2008, Leukemia.

Large‐bore central venous catheters for the collection of peripheral blood stem cells

H. Goldschmidt, H. Salwender, R. Haas, 1995, Journal of clinical apheresis.

Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study

Dhara N. Amin, N. Johnson, M. Krem, 2023, American journal of hematology.

Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial.

M. Roberts, S. Peake, Morgyn S. Warner, 2015, The Journal of antimicrobial chemotherapy.

Increased risk of catheter colonization and catheter-related infections in severe immunocompromized patients with multiple myeloma undergoing high-dose glucocorticoid treatment.

H. Goldschmidt, U. Hegenbart, B. Jansen, 1998, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

Results of a Phase 2, Randomized, Double-Blind Study of Sorafenib Versus Placebo in Combination with Intensive Chemotherapy in Previously Untreated Patients with FLT3-ITD Acute Myeloid Leukemia (ALLG AMLM16)

P. Marlton, A. Roberts, A. Wei, 2020 .

A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia

J. Szer, I. Lewis, P. Marlton, 2014, British journal of haematology.

Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome.

G. Gores, P. Galle, R. Seufert, 2004, Gastroenterology.

Mannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantation.

C. Mullighan, J. Szer, S. Heatley, 2006, Blood.

MANNOSE-BINDING LECTIN STATUS IS ASSOCIATED WITH RISK OF MAJOR INFECTION FOLLOWING MYELOABLATIVE SIBLING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION Short title: MBL status and infection following allo-HCT

C. Mullighan, J. Szer, S. Heatley, 2008 .

Pharmacokinetic and Pharmacodynamic Comparison of Enteric‐Coated Mycophenolate Sodium and Mycophenolate Mofetil in Maintenance Renal Transplant Patients

K. Budde, F. Diekmann, P. Glander, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14

M. Gandhi, I. Lewis, R. Hicks, 2017, Haematologica.

Central venous catheter-related complications.

H. Goldschmidt, A. Ho, A. Bach, 2000, Antibiotics and chemotherapy.

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma

I. Lossos, J. Burke, B. Cheson, 2022, Blood advances.

Cellular origin and lineage specificity of the JAK2(V617F) allele in polycythemia vera.

I. Lewis, L. To, U. Hahn, 2007, Blood.

Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients

S. Peake, S. Shakib, J. Roberts, 2023, Antimicrobial agents and chemotherapy.

polycythemia vera allele in V617F Cellular origin and lineage specificity of the JAK2

I. Lewis, L. To, U. Hahn, 2011 .

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Early Stage Classic Hodgkin Lymphoma: Interim Efficacy and Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part C)

J. Burke, N. Bartlett, H. Prince, 2022, Blood.

M. Roberts, S. Peake, J. Roberts, 2017, Antimicrobial Agents and Chemotherapy.

Abstract CT133: Targeting BCL-2 and MCL-1 overcomes treatment resistance in relapsed and refractory non-Hodgkin lymphoma: Pre-clinical rationale and results from an open-label phase 1b study

Dhara N. Amin, C. Flowers, M. Krem, 2020 .

Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Updated Analysis of a Phase I/II Study

I. Lossos, J. Burke, B. Cheson, 2019, Blood.

Activating killer cell immunoglobulin like receptor haplotype influences clinical outcome following HLA matched sibling haematopoietic stem cell transplantation

C. Mullighan, J. Szer, S. Heatley, 2019 .